Competing in the Global Pharmaceutical Market 2/3

Mr. Masao Torii, President and Representative Director of Boehringer Ingelheim Japan, Inc. discusses current trends in the Global Pharmaceutical Market. Mr. Torii describes how Boehringer Ingelheim, one of the world’s largest pharmaceutical companies, uses its uniqueness and strengths to succeed globally. He also describes his company’s role in the Japanese pharmaceutical market, including how the corporate values of Boehringer Ingelheim Japan help cultivate global leaders within the company. This seminar provides guidance and insight for people interested in strategies to compete globally as well as how to develop your own skills to become a global leader.

Follow @GLOBIS_Insights

Watch from Part1

Professional Seminar:
"Competing in the Global Pharmaceutical Market: Utilizing Uniqueness to Succeed −Thoughts on Global Leadership in Japan" Part2


Speaker: Mr. Masao Torii, President, Boehringer Ingelheim Japan, Inc.
Time and Date: 19:00 - 21:00, Tuesday, September 18, 2012
Venue: GLOBIS University, Tokyo, Japan
Language: English
Duration: 45:37

About Boehringer Ingelheim
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

Boehringer Ingelheim has been developing its business in Japan for some 50 years. As a holding company, Boehringer Ingelheim Japan, Inc. manages four business segments under the following companies: Nippon Boehringer Ingelheim Co., Ltd. (prescription medicine), SSP CO., LTD. (Consumer Health Care), Boehringer Ingelheim Vetmedica Japan (veterinary medicines), and Boehringer Ingelheim Seiyaku (manufacture of pharmaceutical products).

Guest Speaker

Mr. Masao Torii is currently the President and Representative Director of Boehringer Ingelheim Japan, Inc., leading 2,700 employees who belong to BI Japan group companies. He also serves as the Chairman and Representative Director of Nippon Boehringer Ingelheim Co., Ltd.; SSP Co., Ltd.; Boehringer Ingelheim Vetmedica Japan Co., Ltd.; and Boehringer Ingelheim Seiyaku. Mr. Torii has over 20 years of experience leading foreign-affiliated companies in Japan, including Schering-Plough K.K., Rhône-Poulenc Roller, Inc., and Nippon Roche K.K..

Mr. Torii holds an MBA in International Business from Sophia University and a BA in Business Administration from Loyola College in Maryland, USA. He was born in 1947 in Kanagawa Prefecture.

Dialogue Partner

At GLOBIS, Mr. Nakamura teaches subjects in the leadership area and has conducted various global training programs to GLOBIS' corporate clients. Prior to GLOBIS, Mr. Nakamura joined Marubeni Corporation and while seconded to Advantage Partners, worked on the reorganizations of invested companies. As General Manager of Fuji Machinery Mfg. & Electronics Corporation, he contributed in the rapid reorganization of the company. As Senior Managing Director at Sun-Life Corporation, he introduced a progressive ESOP for more than 250 employees, including part-time workers. Mr. Nakamura also writes a column, "Ki and Management" periodically at GLOBIS.JP. Mr. Nakamura earned his MBA from Harvard Business School and a BA from Hitotsubashi University.

PAGE
TOP